Drug‐Specific Calibration: A Solution to Reagent Variability in Extended Half‐Life Factor IX Activity Measurements
Haemophilia · 2025
DOI: 10.1111/hae.70115 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Haemophilia, 2025. Verfasst von François Grand und 19 weiteren Autor:innen. Beteiligte Einrichtung: CHU de Poitiers, Laboratoire d'hématologie biologique, Poitiers, France. Hauptthemen laut MEDLINE: Factor IX. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Introduction
Discrepancies in factor IX activity (FIX:C) measurements between one‐stage clotting assays (OSAs) have been observed following infusion with recombinant factor IX extended half‐life concentrates (EHL‐rFIX) in the treatment of haemophilia B. These variations, primarily due to differences in activated partial thromboplastin time (APTT) reagents, complicate clinical decision‐making.
Objectives
The aim of this study was to evaluate whether drug‐specific calibrations for albumin‐fused recombinant FIX (rFIX‐FP) and Fc‐fused recombinant FIX (rFIX‐Fc) could reduce inter‐reagent discrepancies.
Methods
In a multicentre field study involving 20 laboratories, plasma samples spiked with rFIX‐FP, rFIX‐Fc or standard rFIX were tested using different APTT reagents. FIX:C was measured with usual and drug‐specific calibration. Data were analysed for compliance (target range: 80%–120% of expected values), interlaboratory variability and intralaboratory reproducibility.
Results
Usual calibration resulted in significant discrepancies among reagents, with compliance rates varying widely. Drug‐specific calibration significantly improved compliance for all reagents tested, except for one concentration with rFIX‐Fc. Interlaboratory variability decreased markedly, with coefficients of variation dropping from 19.4%–36.0% (usual calibration) to 6.0%–12.4% (specific calibration). Intralaboratory reproducibility was consistent whatever the type of calibration.
Conclusion
Drug‐specific calibration for EHL‐rFIX reduces reagent‐related variability in OSA FIX assays, ensuring reliable and standardised results. This approach facilitates monitoring with a single reagent system, improving laboratory efficiency. Wider availability of validated calibrators remains crucial for broader adoption and standardisation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CHU de Poitiers, Laboratoire d'hématologie biologique, Poitiers, France.
- Laboratoire d'hématologie, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France.
- Laboratoire de Biologie Médicale, Secteur d'Hémostase Biologique, CHU Besançon, Besançon, France.
- CHU de Bordeaux, Hôpital Cardiologique, Laboratoire d'Hémostase, Pessac Cedex, France.
- Service d'Hématologie Biologique, CHRU de Nancy, Nancy, France.
- Laboratoire d'Hématologie, CHU Caen Normandie, Caen, France.
ORCID-Profile: François Grand, Dominique Lasne, Claire Flaujac, Laurent Sattler, Christophe Nougier
Zitieren
APA
Grand, F., Blanc-Jouvan, F., Mourey, G., Ryman, A., Eschwege, V., Brionne-François, M., Lasne, D., Voisin, S., Le Cam-Duchez, V., Diaz-Cau, I., Flaujac, C., Noyel, P., Lavenu-Bombled, C., Demaistre, E., Jeanpierre, E., Donnard, M., Pouplard, C., Hezard, N., Sattler, L., & Nougier, C. (2025). Drug‐Specific Calibration: A Solution to Reagent Variability in Extended Half‐Life Factor IX Activity Measurements. Haemophilia. https://doi.org/10.1111/hae.70115
Vancouver
Grand F, Blanc-Jouvan F, Mourey G, Ryman A, Eschwege V, Brionne-François M, et al. Drug‐Specific Calibration: A Solution to Reagent Variability in Extended Half‐Life Factor IX Activity Measurements. Haemophilia. 2025. doi:10.1111/hae.70115
BibTeX
@article{Grand2025,
author = {Grand, François and Blanc-Jouvan, Florence and Mourey, Guillaume and Ryman, Anne and Eschwege, Valérie and Brionne-François, Marie and Lasne, Dominique and Voisin, Sophie and Le Cam-Duchez, Véronique and Diaz-Cau, Isabelle and Flaujac, Claire and Noyel, Pauline and Lavenu-Bombled, Cecile and Demaistre, Emmanuel and Jeanpierre, Emmanuelle and Donnard, Magali and Pouplard, Claire and Hezard, Nathalie and Sattler, Laurent and Nougier, Christophe},
title = {Drug‐Specific Calibration: A Solution to Reagent Variability in Extended Half‐Life Factor IX Activity Measurements},
journal = {Haemophilia},
year = {2025},
doi = {10.1111/hae.70115}
}
EUVIMED